PubMed Health⌕ Search

Biomedical subjects

B Bigorie

Publications and source records attributed to B Bigorie.

13 recordsLinked to original sources
PubMed1975

[Is triacetyl oleandomycin-ergotamine tartrate combination dangerous?].

The authors report a case of ischaemia of all four limbs in an adolescent following the simultaneous ingestion of triacetyl oleandomycin and ergotamine tartrate in low dosage. Two cases involving this same association of medications have appeared in the literature and attention is therefore drawn to the possible danger of use of these two drugs together.

Adolescent↗
PubMed1975

Effect of fat cell size, restrictive diet and diabetes on lipoprotein lipase release by human adipose tissue.

The lipoprotein lipase activity (LPLA) eluted from human adipose tissue was measured after percutaneous biopsy in the fasting state. A positive and significant correlation was found between LPLA per 10(6) cells or per cell surface unit and cell volume in 27 normal and obese subjects in weight balance and on maintenance diet. Such a correlation was also found in 13 diabetic subjects before treatment. In 11 obese subjects subjected to a restricted diet, LPLA dropped dramatically without a significant change in cell size, blunting the cell size effect. In diabetic subjects the LPLA per cell was significantly lower than in nondiabetic people with similar adipose cell volume.

Adipose Tissue↗
PubMedDate not supplied

[Paradoxical effects of iodine overload on thyroid function].

Any chronic iodine overload resulting from long term ingestion of a medication or the administration of a non-resorbable contrast medium, may result in a goitre with or without hypothyroidism, and in particular in patients with a past history of thyroid disease. By contrast, the administration of iodine is no longer indicated in the treatment of enedmic goitres since the hypothesis of an iodine deficiency in the pathogenesis of such goitres may be excluded in most countries, and in particular western countries, and the risk of the development of thyrotoxicosis in such patients is not negligeable. It would thus be desirable that iodine no longer be used in the composition of medications when its presence is not indispensalbe and where, furthermore, it may contribute to developement of an increasingly disturbing iatrogenic complication.

Aged↗